3 ·Filed Jul 13, 2026

LGVN

Longeveron Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001214659-26-008493
Actionable Insight • Neutral

These are routine initial ownership disclosures for new Section 16 filers with no holdings. No trading signal. Monitor subsequent Form 4 filings for any open-market purchases or grants that would indicate insider conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
LGVN ▲ +11.22% at T+20d
NEUTRAL call ✓ call won +11.22% · α vs SPY +8.73% · entry $0.6223 → $0.6921
Next anchor: T+60d in 4d
Latest observation: T+57 -28.24% FF3 residual α
Entry anchored
Jul 13, 03:59 PM ET
via exchange tick
T+1d
+2.09%
call +2.09% · α +1.69%
$0.6353
settled 3mo ago
T+5d
-3.23%
call -3.23% · α -1.93%
$0.6022
settled 2mo ago
T+20d
+11.22%
call +11.22% · α +8.73%
$0.6921
settled 8w ago
T+60d
—
call — · α —
—
in 4d

Price Chart

Loading chart...

Executive Summary

Two new insiders (Leah Rush Cann and Deborah Ascheim) filed initial beneficial ownership statements on Form 3, each reporting zero shares of Longeveron Class A Common Stock as of July 1, 2026. The filings are routine compliance documents that include standard powers of attorney authorizing officers to file future Section 16 reports. No stock price impact is expected.

Key Facts

  • Leah Rush Cann and Deborah Ascheim each filed Form 3 initial statements of beneficial ownership on July 13, 2026.
  • Each reporting person reported zero shares of Longeveron Class A Common Stock beneficially owned.
  • Both filings include an Exhibit 24 Limited Power of Attorney authorizing Paul T. Lehr, Lisa A. Locklear, and Marie Washburn to file Forms 3, 4, and 5 on their behalf.
  • The reporting period for both filings is July 1, 2026.

Financial Impact

Zero shares reported by both new filers — no economic impact.

Risk Factors

  • No material risk identified from these filings alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 16 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (LGVN) — Batch item 10001214659-26-008493
Document: 0001214659-26-008493-index-headers.html0001214659-26-008492
Document: 0001214659-26-008493-index.html0001214659-26-008493
Document: 0001214659-26-008493.txt0001214659-26-008492
3 Filing (LGVN) — Batch item 50001214659-26-008492
Document: 0001214659-26-008492-index-headers.html0001214659-26-008493
Document: 0001214659-26-008492-index.html0001214659-26-008493
Document: 0001214659-26-008492.txt0001214659-26-008493
3 Filing (LGVN) — Batch item 90001214659-26-008493
Document: 0001214659-26-008493-index-headers.html0001214659-26-008493
Document: 0001214659-26-008493-index.html0001214659-26-008493
Document: 0001214659-26-008493.txt0001214659-26-008493
3 Filing (LGVN) — Batch item 130001214659-26-008492
Document: 0001214659-26-008492-index-headers.html0001214659-26-008493
Document: 0001214659-26-008492-index.html0001214659-26-008493
Document: 0001214659-26-008492.txt0001214659-26-008493
12 reports for LGVN
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +42.59%Apr 10, 2026
Filters
Rows
Reports for LGVN — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
8-K
BULLISH ★ 5/10
$6.86 $2.49▼ −63.70%▼ −64.52%$2.57 (−62.61%)
Jul 13, 2026
11w ago
3
NEUTRAL ★ 2/10
$0.6223 $0.6022▼ −3.23%▼ −1.93%$2.57 (+312.18%)
Jun 5, 2026
16w ago
8-K
NEUTRAL ★ 4/10
$0.7540 $0.7900▲ +4.77%▲ +2.66%$2.57 (+240.19%)
May 20, 2026
19w ago
Press Release
NEUTRAL ★ 4/10
$0.7210 $0.8150▲ +13.04%▲ +11.44%$2.57 (+255.76%)
May 13, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$0.7030 $0.7210▲ +2.56%▲ +3.28%$2.57 (+264.86%)
May 8, 2026
20w ago
8-K
BEARISH ★ 7/10
$0.8380 $0.6760▲ +19.33%▲ +19.25%$2.57 (−206.09%)
Apr 20, 2026
23w ago
EFFECT
BEARISH ★ 6/10
$1.04 $0.9000▲ +13.46%▲ +14.37%$2.57 (−146.63%)
Apr 10, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$1.12 $1.04▼ −7.14%▼ −10.44%$2.57 (+129.02%)
Apr 10, 2026
24w ago
S-1
BEARISH ★ 6/10
$1.12 $1.04▲ +7.14%▲ +10.44%$2.57 (−129.02%)
Mar 17, 2026
28w ago
Press Release
BEARISH ★ 7/10
$0.9760 $0.9730▲ +0.31%▼ −0.41%$2.57 (−162.81%)
Showing 10 of 12

US Market Status

Market Open — Closes in 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access